Comprehensive bioinformatics and machine learning analysis identify VCAN as a novel biomarker of hepatitis B virus-related liver fibrosis

Hepatitis B virus (HBV) infection remains the leading cause of liver fibrosis (LF) worldwide, especially in China. Identification of decisive diagnostic biomarkers for HBV-associated liver fibrosis (HBV-LF) is required to prevent chronic hepatitis B (CHB) from progressing to liver cancer and to more...

Full description

Bibliographic Details
Main Authors: Mengqin Yuan, Xue Hu, Lichao Yao, Pingji Liu, Yingan Jiang, Lanjuan Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Molecular Biosciences
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2022.1010160/full
_version_ 1828194981137874944
author Mengqin Yuan
Xue Hu
Lichao Yao
Pingji Liu
Yingan Jiang
Lanjuan Li
Lanjuan Li
author_facet Mengqin Yuan
Xue Hu
Lichao Yao
Pingji Liu
Yingan Jiang
Lanjuan Li
Lanjuan Li
author_sort Mengqin Yuan
collection DOAJ
description Hepatitis B virus (HBV) infection remains the leading cause of liver fibrosis (LF) worldwide, especially in China. Identification of decisive diagnostic biomarkers for HBV-associated liver fibrosis (HBV-LF) is required to prevent chronic hepatitis B (CHB) from progressing to liver cancer and to more effectively select the best treatment strategy. We obtained 43 samples from CHB patients without LF and 81 samples from CHB patients with LF (GSE84044 dataset). Among these, 173 differentially expressed genes (DEGs) were identified. Functional analysis revealed that these DEGs predominantly participated in immune-, extracellular matrix-, and metabolism-related processes. Subsequently, we integrated four algorithms (LASSO regression, SVM-RFE, RF, and WGCNA) to determine diagnostic biomarkers for HBV-LF. These analyses and receive operating characteristic curves identified the genes for phosphatidic acid phosphatase type 2C (PPAP2C) and versican (VCAN) as potentially valuable diagnostic biomarkers for HBV-LF. Single-sample gene set enrichment analysis (ssGSEA) further confirmed the immune landscape of HBV-LF. The two diagnostic biomarkers also significantly correlated with infiltrating immune cells. The potential regulatory mechanisms of VCAN underlying the occurrence and development of HBV-LF were also analyzed. These collective findings implicate VCAN as a novel diagnostic biomarker for HBV-LF, and infiltration of immune cells may critically contribute to the occurrence and development of HBV-LF.
first_indexed 2024-04-12T09:35:22Z
format Article
id doaj.art-2d8744ab041e4b33883efe12598a6aeb
institution Directory Open Access Journal
issn 2296-889X
language English
last_indexed 2024-04-12T09:35:22Z
publishDate 2022-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Molecular Biosciences
spelling doaj.art-2d8744ab041e4b33883efe12598a6aeb2022-12-22T03:38:15ZengFrontiers Media S.A.Frontiers in Molecular Biosciences2296-889X2022-10-01910.3389/fmolb.2022.10101601010160Comprehensive bioinformatics and machine learning analysis identify VCAN as a novel biomarker of hepatitis B virus-related liver fibrosisMengqin Yuan0Xue Hu1Lichao Yao2Pingji Liu3Yingan Jiang4Lanjuan Li5Lanjuan Li6Department of Infectious Diseases, Renmin Hospital of Wuhan University, Wuhan, Hubei, ChinaDepartment of Infectious Diseases, Renmin Hospital of Wuhan University, Wuhan, Hubei, ChinaDepartment of Infectious Diseases, Renmin Hospital of Wuhan University, Wuhan, Hubei, ChinaDepartment of Infectious Diseases, Renmin Hospital of Wuhan University, Wuhan, Hubei, ChinaDepartment of Infectious Diseases, Renmin Hospital of Wuhan University, Wuhan, Hubei, ChinaDepartment of Infectious Diseases, Renmin Hospital of Wuhan University, Wuhan, Hubei, ChinaState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Centre for Infectious Diseases, Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, ChinaHepatitis B virus (HBV) infection remains the leading cause of liver fibrosis (LF) worldwide, especially in China. Identification of decisive diagnostic biomarkers for HBV-associated liver fibrosis (HBV-LF) is required to prevent chronic hepatitis B (CHB) from progressing to liver cancer and to more effectively select the best treatment strategy. We obtained 43 samples from CHB patients without LF and 81 samples from CHB patients with LF (GSE84044 dataset). Among these, 173 differentially expressed genes (DEGs) were identified. Functional analysis revealed that these DEGs predominantly participated in immune-, extracellular matrix-, and metabolism-related processes. Subsequently, we integrated four algorithms (LASSO regression, SVM-RFE, RF, and WGCNA) to determine diagnostic biomarkers for HBV-LF. These analyses and receive operating characteristic curves identified the genes for phosphatidic acid phosphatase type 2C (PPAP2C) and versican (VCAN) as potentially valuable diagnostic biomarkers for HBV-LF. Single-sample gene set enrichment analysis (ssGSEA) further confirmed the immune landscape of HBV-LF. The two diagnostic biomarkers also significantly correlated with infiltrating immune cells. The potential regulatory mechanisms of VCAN underlying the occurrence and development of HBV-LF were also analyzed. These collective findings implicate VCAN as a novel diagnostic biomarker for HBV-LF, and infiltration of immune cells may critically contribute to the occurrence and development of HBV-LF.https://www.frontiersin.org/articles/10.3389/fmolb.2022.1010160/fullhepatitis B virus-related liver fibrosisdiagnostic biomarkerbioinformatic analysismachine-learning strategiesimmune cell infiltration
spellingShingle Mengqin Yuan
Xue Hu
Lichao Yao
Pingji Liu
Yingan Jiang
Lanjuan Li
Lanjuan Li
Comprehensive bioinformatics and machine learning analysis identify VCAN as a novel biomarker of hepatitis B virus-related liver fibrosis
Frontiers in Molecular Biosciences
hepatitis B virus-related liver fibrosis
diagnostic biomarker
bioinformatic analysis
machine-learning strategies
immune cell infiltration
title Comprehensive bioinformatics and machine learning analysis identify VCAN as a novel biomarker of hepatitis B virus-related liver fibrosis
title_full Comprehensive bioinformatics and machine learning analysis identify VCAN as a novel biomarker of hepatitis B virus-related liver fibrosis
title_fullStr Comprehensive bioinformatics and machine learning analysis identify VCAN as a novel biomarker of hepatitis B virus-related liver fibrosis
title_full_unstemmed Comprehensive bioinformatics and machine learning analysis identify VCAN as a novel biomarker of hepatitis B virus-related liver fibrosis
title_short Comprehensive bioinformatics and machine learning analysis identify VCAN as a novel biomarker of hepatitis B virus-related liver fibrosis
title_sort comprehensive bioinformatics and machine learning analysis identify vcan as a novel biomarker of hepatitis b virus related liver fibrosis
topic hepatitis B virus-related liver fibrosis
diagnostic biomarker
bioinformatic analysis
machine-learning strategies
immune cell infiltration
url https://www.frontiersin.org/articles/10.3389/fmolb.2022.1010160/full
work_keys_str_mv AT mengqinyuan comprehensivebioinformaticsandmachinelearninganalysisidentifyvcanasanovelbiomarkerofhepatitisbvirusrelatedliverfibrosis
AT xuehu comprehensivebioinformaticsandmachinelearninganalysisidentifyvcanasanovelbiomarkerofhepatitisbvirusrelatedliverfibrosis
AT lichaoyao comprehensivebioinformaticsandmachinelearninganalysisidentifyvcanasanovelbiomarkerofhepatitisbvirusrelatedliverfibrosis
AT pingjiliu comprehensivebioinformaticsandmachinelearninganalysisidentifyvcanasanovelbiomarkerofhepatitisbvirusrelatedliverfibrosis
AT yinganjiang comprehensivebioinformaticsandmachinelearninganalysisidentifyvcanasanovelbiomarkerofhepatitisbvirusrelatedliverfibrosis
AT lanjuanli comprehensivebioinformaticsandmachinelearninganalysisidentifyvcanasanovelbiomarkerofhepatitisbvirusrelatedliverfibrosis
AT lanjuanli comprehensivebioinformaticsandmachinelearninganalysisidentifyvcanasanovelbiomarkerofhepatitisbvirusrelatedliverfibrosis